EUVIMEDEUVIMED entdecken
Crossref

Oxygen‐Deficient Molybdenum Oxide Nanosensitizers for Ultrasound‐Enhanced Cancer Metalloimmunotherapy

Yuanjie Wang, Fei Gong, Zhihui Han, Huali Lei, Yangkai Zhou, Shuning Cheng, Xiaoyuan Yang, Tianyi Wang, Li Wang, Nailin Yang, Zhuang Liu, Liang Cheng iD

Angewandte Chemie International Edition · 2023

DOI: 10.1002/anie.202215467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Yuanjie Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University,…. Hauptthemen laut MEDLINE: Oxides, Neoplasms. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxygen‐deficient molybdenum oxide (MoO X ) nanomaterials are prepared as novel nanosensitizers and TME‐stimulants for ultrasound (US)‐enhanced cancer metalloimmunotherapy. After PEGylation, MoO X ‐PEG exhibits efficient capability for US‐triggered reactive oxygen species (ROS) generation and glutathione (GSH) depletion. Under US irradiation, MoO X ‐PEG generates a massive amount of ROS to induce cancer cell damage and immunogenic cell death (ICD), which can effectively suppress tumor growth. More importantly, MoO X ‐PEG itself further stimulates the maturation of dendritic cells (DCs) and triggeres the activation of the cGAS‐STING pathway to enhance the immunological effect. Due to the robust ICD induced by SDT and efficient DC maturation stimulated by MoO X ‐PEG, the combination treatment of MoO X ‐triggered SDT and aCTLA‐4 further amplifies antitumor therapy, inhibits cancer metastases, and elicits robust immune responses to effectively defeat abscopal tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxidesNeoplasmsHumansReactive Oxygen SpeciesMolybdenumHypoxiaOxygenCell Line, Tumor

Stichwörter der Autor:innen

DC MaturationMetalloimmunotherapyMolybdenum OxideSonodynamic TherapycGAS-STING Pathway

Substanzen

Reactive Oxygen SpeciesOxidesMolybdenummolybdenum oxideOxygen

Autor:innen und Institutionen

  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, 215123, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, 215000, China.

ORCID-Profile: Liang Cheng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Gong, F., Han, Z., Lei, H., Zhou, Y., Cheng, S., Yang, X., Wang, T., Wang, L., Yang, N., Liu, Z., & Cheng, L. (2023). Oxygen‐Deficient Molybdenum Oxide Nanosensitizers for Ultrasound‐Enhanced Cancer Metalloimmunotherapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202215467

Vancouver

Wang Y, Gong F, Han Z, Lei H, Zhou Y, Cheng S, et al. Oxygen‐Deficient Molybdenum Oxide Nanosensitizers for Ultrasound‐Enhanced Cancer Metalloimmunotherapy. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202215467

BibTeX
@article{Wang2023,
  author = {Wang, Yuanjie and Gong, Fei and Han, Zhihui and Lei, Huali and Zhou, Yangkai and Cheng, Shuning and Yang, Xiaoyuan and Wang, Tianyi and Wang, Li and Yang, Nailin and Liu, Zhuang and Cheng, Liang},
  title = {Oxygen‐Deficient Molybdenum Oxide Nanosensitizers for Ultrasound‐Enhanced Cancer Metalloimmunotherapy},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  doi = {10.1002/anie.202215467}
}
Kostenlos starten →